Back
  1. Home
  2. Profile of Deborah Crombez (UMONS)
Profil

Crombez Deborah

Main Referenced Co-authors
MULLER, Robert  (14)
BURTEA, Carmen  (13)
Scaux, Géraldine (5)
Vander elst, Luce  (5)
LAURENT, Sophie  (4)
Main Referenced Keywords
AMPK (4); diabetes (4); peptides (4); phage display (4); therapy (4);
Main Referenced Unit & Research Centers
CMMI - Centre de Recherche en Microscopie et Imagerie Médicale (14)
Main Referenced Disciplines
Immunology & infectious disease (9)
Endocrinology, metabolism & nutrition (7)
Pharmacy, pharmacology & toxicology (7)
Zoology (7)
Biotechnology (5)

Publications (total 14)

The most downloaded
17 downloads
Stanicki, D., Boutry, S., Laurent, S., Wacheul, L., Nicolas, E., Crombez, D., Vander Elst, L., Lafontaine, D., & Muller, R. (03 March 2014). Carboxy-silane coated iron oxide nanoparticles: a convenient platform for cellular and small animal imaging. Journal of Materials Chemistry B, 2 (4), 387-397. https://hdl.handle.net/20.500.12907/38055

The most cited

34 citations (Scopus®)

Stanicki, D., Boutry, S., Laurent, S., Wacheul, L., Nicolas, E., Crombez, D., Vander Elst, L., Lafontaine, D., & Muller, R. (03 March 2014). Carboxy-silane coated iron oxide nanoparticles: a convenient platform for cellular and small animal imaging. Journal of Materials Chemistry B, 2 (4), 387-397. https://hdl.handle.net/20.500.12907/38055

Crombez, D., Vander Elst, L., Muller, R., & Burtea, C. (18 May 2016). Nouvelle stratégie thérapeutique du diabète de type 2 : activation de la voie AMPK via un agoniste peptidique des récepteurs de l'adiponectine [Poster presentation]. 9ème édition de la Matinée des Chercheurs 2016 (MdC2016), Valenciennes, France.

Crombez, D., Muller, R., & Burtea, C. (04 May 2016). Potential therapeutic peptides targeted to adiponectin receptors, able to modulate the AMPK pathway and regulate the glucose and lipid metabolism [Paper presentation]. Diabetes Kongress, Berlin, Germany.

Crombez, D., Muller, R., & Burtea, C. (04 May 2016). Potential therapeutic peptides targeted to adiponectin receptors, able to modulate the AMPK pathway and regulate the glucose and lipid metabolism [Poster presentation]. Diabetes Kongress, Berlin, Germany.

Crombez, D., Muller, R., & Burtea, C. (17 February 2016). Type 2 diabetes and metabolic syndrome : agonist peptides targeted to adiponectin receptors are new therapeutic strategy by activation of AMPK pathway [Poster presentation]. Belgian Peptide Group Meeting, Bruxelles, Belgium.

Ansciaux, E., Burtea, C., Laurent, S., Crombez, D., Nonclercq, D., Vander Elst, L., & Muller, R. (05 June 2015). In vitro and in vivo characterization of several functionalized USPIO vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging. Contrast Media and Molecular Imaging, 10 (3), 211-224. doi:10.1002/CMMI.1626
Peer Reviewed verified by ORBi

Crombez, D., Scaux, G., Muller, R., & Burtea, C. (22 May 2015). A metabolic therapy of Type 2 Diabetes : AMPK activation by agonist peptides targeted to adiponectin receptors [Poster presentation]. Journée d'études UMHAP - from lab to bedside, UMONS, Belgium.

Crombez, D., Scaux, G., Muller, R., & Burtea, C. (13 May 2015). A metabolic therapy of Type 2 Diabetes : AMPK activation by agonist peptides targeted to adiponectin receptors [Poster presentation]. Bioforum 2015- ULG, Liège, Belgium.

Crombez, D., Scaux, G., Muller, R., & Burtea, C. (10 March 2015). Development of an Adiponectin Receptor Agonist for the Metabolic Therapy of Type 2 Diabetes [Poster presentation]. 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium.

Burtea, C., Laurent, S., Crombez, D., Delcambre, S., Sermeus, C., Millard, I., Rorive, S., Flamez, D., Beckers, M.-C., Salmon, I., Vander Elst, L., Eizirik, D., & Muller, R. (18 February 2015). Development of a peptide-functionalized imaging nanoprobe for the targeting of (FXYD2)gamma-a as a highly specific biomarker of pancreatic beta cells. Contrast Media and Molecular Imaging, 10 (5), 398-412. doi:10.1002/cmmi.1641
Peer Reviewed verified by ORBi

Crombez, D., Laurent, S., Scaux, G., Vander Elst, L., Muller, R., & Burtea, C. (16 January 2015). Development of a molecular approach for the monitoring and treatment of diabetic patients [Poster presentation]. 7th annual meeting ISMRM Benelux, Ghent, Belgium.

Crombez, D., Scaux, G., Muller, R., & Burtea, C. (18 November 2014). Thérapie métabolique des troubles liés au diabète de type 2 via le développement d'un agoniste du récepteur de l'adiponectine [Poster presentation]. Biomarqueurs d'imagerie du métabolisme et du risque cardio-vasculaire, Lyon, France.

Stanicki, D., Boutry, S., Laurent, S., Wacheul, L., Nicolas, E., Crombez, D., Vander Elst, L., Lafontaine, D., & Muller, R. (03 March 2014). Carboxy-silane coated iron oxide nanoparticles: a convenient platform for cellular and small animal imaging. Journal of Materials Chemistry B, 2 (4), 387-397.
Peer Reviewed verified by ORBi

Crombez, D., Delcambre, S., Muller, R., & Burtea, C. (10 February 2014). Development of a peptide agonist of adiponectin receptor for the therapy of type 2 diabetes and metabolic syndrome [Poster presentation]. Belgian Peptide Meeting, Ghent, Belgium.

Crombez, D., Burtea, C., & Muller, R. (24 May 2013). Therapy of type 2 diabetes: development of an agonist of adiponectin receptor [Poster presentation]. 1st Health Institute Day, Mons, Belgium.

Contact ORBi UMONS